Literature DB >> 30852773

Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.

George Makavos1, Chris Κairis1, Maria-Eirini Tselegkidi2, Theodoros Karamitsos3, Angelos G Rigopoulos4, Michel Noutsias4, Ignatios Ikonomidis5.   

Abstract

Hypertrophic cardiomyopathy (HCM) represents a phenotype of left ventricular hypertrophy unexplained by abnormal loading conditions. The definition is based on clinical criteria; however, there are numerous underlying etiologic factors. The MOGE(S) classification provides a standardized approach for multimodal characterization of HCM. HCM is associated with increased morbidity and mortality, and especially the assessment of the risk of sudden cardiac death is of paramount importance. In this review, we summarize essential knowledge and recently published data on clinical presentation, diagnosis, genetic analyses, differential diagnosis, prognosis, and treatment options that are necessary for understanding and management of HCM.

Entities:  

Keywords:  Diagnosis; Etiology; Hypertrophic cardiomyopathy; Treatment

Mesh:

Year:  2019        PMID: 30852773     DOI: 10.1007/s10741-019-09775-4

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  123 in total

1.  Assessing Myocardial Extracellular Volume by T1 Mapping to Distinguish Hypertrophic Cardiomyopathy From Athlete's Heart.

Authors:  Peter P Swoboda; Adam K McDiarmid; Bara Erhayiem; David A Broadbent; Laura E Dobson; Pankaj Garg; Carrie Ferguson; Stephen P Page; John P Greenwood; Sven Plein
Journal:  J Am Coll Cardiol       Date:  2016-05-10       Impact factor: 24.094

2.  Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Gabriele E Assenza; Tammy S Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; Ethan Rowin; James Udelson; Massimo Lombardi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Martina P Marra; Elena Biagini; Camillo Autore; Warren J Manning; Evan Appelbaum; William C Roberts; Cristina Basso; Martin S Maron
Journal:  Am J Cardiol       Date:  2015-05-08       Impact factor: 2.778

3.  Prognostic Significance of Fragmented QRS in Patients with Hypertrophic Cardiomyopathy.

Authors:  Xili Lu; Wei Wang; Ling Zhu; Yilu Wang; Kai Sun; Yubao Zou; Tao Tian; Rutai Hui; Jizheng Wang; Lianming Kang; Lei Song
Journal:  Cardiology       Date:  2017-05-30       Impact factor: 1.869

4.  Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.

Authors:  Carolyn Y Ho; Neal K Lakdawala; Allison L Cirino; Steven E Lipshultz; Elizabeth Sparks; Siddique A Abbasi; Raymond Y Kwong; Elliott M Antman; Christopher Semsarian; Arantxa González; Begoña López; Javier Diez; E John Orav; Steven D Colan; Christine E Seidman
Journal:  JACC Heart Fail       Date:  2014-10-31       Impact factor: 12.035

5.  Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice.

Authors:  Cesare Cuspidi; Francesca Negri; Maria Lorenza Muiesan; Anna Capra; Laura Lonati; Alberto Milan; Carla Sala; Marcella Longo; Alberto Morganti
Journal:  Blood Press       Date:  2010-09-09       Impact factor: 2.835

6.  Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.

Authors:  Martin S Maron; Iacopo Olivotto; Andrey G Zenovich; Mark S Link; Natesa G Pandian; Jeffery T Kuvin; Stefano Nistri; Franco Cecchi; James E Udelson; Barry J Maron
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

Review 7.  The MOGE(S) classification for cardiomyopathies: current status and future outlook.

Authors:  Julian G Westphal; Angelos G Rigopoulos; Constantinos Bakogiannis; Sarah E Ludwig; Sophie Mavrogeni; Boris Bigalke; Torsten Doenst; Matthias Pauschinger; Carsten Tschöpe; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

8.  Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.

Authors:  Andre Rudolph; Hassan Abdel-Aty; Steffen Bohl; Philipp Boyé; Anja Zagrosek; Rainer Dietz; Jeanette Schulz-Menger
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

9.  Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.

Authors:  Josef Veselka; Morten Kvistholm Jensen; Max Liebregts; Jaroslav Januska; Jan Krejci; Thomas Bartel; Maciej Dabrowski; Peter Riis Hansen; Vibeke Marie Almaas; Hubert Seggewiss; Dieter Horstkotte; Pavol Tomasov; Radka Adlova; Henning Bundgaard; Robbert Steggerda; Jurriën Ten Berg; Lothar Faber
Journal:  Eur Heart J       Date:  2016-01-07       Impact factor: 29.983

10.  Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

Authors:  R O Cannon; D R Rosing; B J Maron; M B Leon; R O Bonow; R M Watson; S E Epstein
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

View more
  18 in total

1.  Real-world clinical validity of cardiac magnetic resonance tissue tracking in primitive hypertrophic cardiomyopathy.

Authors:  Pierpaolo Palumbo; Francesco Masedu; Camilla De Cataldo; Ester Cannizzaro; Federico Bruno; Silvia Pradella; Francesco Arrigoni; Marco Valenti; Alessandra Splendiani; Antonio Barile; Andrea Giovagnoni; Carlo Masciocchi; Ernesto Di Cesare
Journal:  Radiol Med       Date:  2021-12-11       Impact factor: 3.469

Review 2.  Contemporary Therapies and Future Directions in the Management of Hypertrophic Cardiomyopathy.

Authors:  Elizabeth Packard; Alejandro de Feria; Supriya Peshin; Nosheen Reza; Anjali Tiku Owens
Journal:  Cardiol Ther       Date:  2022-10-15

3.  A new stone for a new path, from "physiology to the bedside".

Authors:  Yin Hua Zhang; Jin Han
Journal:  Pflugers Arch       Date:  2019-07-03       Impact factor: 3.657

4.  Soluble ST2, Galectin-3 and clinical prognosis of patients with hypertrophic cardiomyopathy undergoing ventricular septal myectomy: a correlation analysis.

Authors:  Bangrong Song; Bo Yao; Haiming Dang; Ran Dong
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

Review 5.  Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.

Authors:  Chrishan J A Ramachandra; Jasper Chua; Shuo Cong; Myu Mai Ja Kp; Winston Shim; Joseph C Wu; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2021-02-22       Impact factor: 10.787

6.  A modified endocardial radiofrequency ablation approach for hypertrophic obstructive cardiomyopathy guided by transthoracic echocardiography: a case series.

Authors:  Lingqiu Kong; Yongchao Zhao; Hongwei Pan; Jianying Ma; Juying Qian; Junbo Ge
Journal:  Ann Transl Med       Date:  2021-06

7.  Hypertrophic cardiomyopathy masked by pericarditis.

Authors:  Larry Nichols; Himara Koelmeyer
Journal:  Autops Case Rep       Date:  2019-09-27

8.  Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction.

Authors:  Yumin Li; Jia Liu; Yukun Cao; Yue Cui; Heshui Shi; Xiaoyu Han; Guozhu Shao; Xiaoyue Zhou; Jin Gu; Tong Liu
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379

Review 9.  Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases.

Authors:  Giovanni Volpato; Umberto Falanga; Laura Cipolletta; Manuel Antonio Conti; Gino Grifoni; Giuseppe Ciliberti; Alessia Urbinati; Alessandro Barbarossa; Giulia Stronati; Marco Fogante; Marco Bergonti; Valentina Catto; Federico Guerra; Andrea Giovagnoni; Antonio Dello Russo; Michela Casella; Paolo Compagnucci
Journal:  Medicina (Kaunas)       Date:  2021-03-25       Impact factor: 2.430

10.  Mitochondrial DNA: Hotspot for Potential Gene Modifiers Regulating Hypertrophic Cardiomyopathy.

Authors:  Parisa K Kargaran; Jared M Evans; Sara E Bodbin; James G W Smith; Timothy J Nelson; Chris Denning; Diogo Mosqueira
Journal:  J Clin Med       Date:  2020-07-23       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.